Pluri
Business Services · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Building No. 5 Matam Advanced Technology...Phone Number
+972 747108600Website
www.pluri-biotech.comRevenue
<$5 MillionStock Symbol
PLURIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Pluri
Pluri Inc. is a biotechnology company focused on developing scalable cell-based technologies for applications in healthcare, food production, and agriculture. The company uses proprietary cell expansion platforms to grow and manufacture biological cells that can be used in regenerative medicine, sustainable food solutions, and other advanced biotechnology applications through partnerships and research initiatives.Explore more
Pluri Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pluri your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Pluri
Funding: Get notified immidiatlly once Pluri has new funding data
Check if Pluri has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Pluri launches new products
Check out if Pluri is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Pluri recently announced quarterly report
Pluri, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Pluri had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Pluri as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Pluri is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pluri is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pluri.
Pluri financials insights
Gather financial insights about Pluri, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$6.5M
Other Financing Round
$3.5M
Pluri Tech Stack
A closer look at the technologies used by Pluri
Most Recent Scoops
Partnership
Partnership, Engineering, Research & Development, Medical Research, Clinical Operations
Person-Based
Person-Based
Person-Based
Person-Based
Pluri News & Media
Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%
Through a series of investments over the past year, including an additional investment made in June 2026, Weinstein has built an ownership position of more than 30% as Pluri advances its longevity and U.S. commercialization strategy Through a series of investments over the past year, including an additional investment made in June 2026, Weinstein has built an ownership position of more than 30% as Pluri advances its longevity and U.S. commercialization strategyPluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing
Two regenerative aesthetic and longevity products, with clinically validated ingredients, are expected to reach the U.S. market during 2026.Pluri Inc. (PLUR): One of the Premier Lab-Grown Meat Stocks to Invest In
We just covered the 7 Best Lab-Grown Meat Stocks to Invest In and Pluri Inc. (NASDAQ:PLUR) ranks 4th on this list. Pluri Inc. (NASDAQ:PLUR), through the highly publicized joint venture, Ever After Foods, utilizes proprietary, state-of-the-art 3D bioreactor systems to cultivate animal cells with unprecedented density and cost efficiency. While most cell-cultured companies struggle with […]Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement
HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (“Pluri” or the “Company”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging a proprietary cell-based platform across multiple commercial verticals, today announced that an entity beneficially owned by Alejandro Weinstein, Chairman of the Board and one of the Company’s largest shareholders, has entered into a Securities Purchase Agreement with Pluri for an additional $2.5 million investment in the Company at a 30% premium to the
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pluri
Sign Up For FreeTo access detailed company insights
Pluri Inc. is a biotechnology company focused on developing scalable cell-based technologies for applications in healthcare, food production, and agriculture. The company uses proprietary cell expansion platforms to grow and manufacture biological cells that can be used in regenerative medicine, sustainable food solutions, and other advanced biotec... Read More
